Screener
Recursion Pharmaceuticals, Inc. RXRX Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Recursion Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
FAQ
- What is Recursion Pharmaceuticals, Inc.'s gross margin?
- Recursion Pharmaceuticals, Inc. (RXRX) reported gross margin of 3.5% in Q2 2026.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s gross margin?
- Over 3 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s gross margin has grown at a -63.2% compound annual growth rate (CAGR), from 100% to 5%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Recursion Pharmaceuticals, Inc.'s gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude